Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Butowski

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|August 19, 2016
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumabSarah J Nelson, Yan Li, Janine M Lupo, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
Seminars in Oncology|September 13, 2014
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe)Maciej M Mrugala, Herbert H Engelhard, David Dinh Tran, et al.
Journal of Neurosurgery|November 4, 2008
Preoperative prognostic classification system for hemispheric low-grade gliomas in adultsEdward F Chang, Justin S Smith, Susan M Chang, et al.
Clinical Neuropathology|July 13, 2017
Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family historyAndrew K Chan, Seunggu J Han, Winward Choy, et al.
Journal of Neuro-Oncology|February 12, 2011
Identifying the needs of brain tumor patients and their caregiversRupa Parvataneni, Mei-Yin Polley, Teresa Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone proteinCourtney A Crane, Seunggu J Han, Brian Ahn, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Neuro-Oncology|December 25, 2012
Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenograftsPin-Yuan Chen, Tomoko Ozawa, Daryl C Drummond, et al.
Journal of Neuro-Oncology|October 14, 2008
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasNicholas Butowski, Kathleen R Lamborn, Bee L Lee, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|August 19, 2016
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumabSarah J Nelson, Yan Li, Janine M Lupo, et al.
Neuro-Oncology|January 31, 2006
Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant gliomaMichael D Prados, Kathleen R Lamborn, Susan Chang, et al.
Seminars in Oncology|September 13, 2014
Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe)Maciej M Mrugala, Herbert H Engelhard, David Dinh Tran, et al.
Journal of Neurosurgery|November 4, 2008
Preoperative prognostic classification system for hemispheric low-grade gliomas in adultsEdward F Chang, Justin S Smith, Susan M Chang, et al.
Clinical Neuropathology|July 13, 2017
Familial melanoma-astrocytoma syndrome: synchronous diffuse astrocytoma and pleomorphic xanthoastrocytoma in a patient with germline CDKN2A/B deletion and a significant family historyAndrew K Chan, Seunggu J Han, Winward Choy, et al.
Journal of Neuro-Oncology|February 12, 2011
Identifying the needs of brain tumor patients and their caregiversRupa Parvataneni, Mei-Yin Polley, Teresa Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 9, 2012
Individual patient-specific immunity against high-grade glioma after vaccination with autologous tumor derived peptides bound to the 96 KD chaperone proteinCourtney A Crane, Seunggu J Han, Brian Ahn, et al.
Neuro-Oncology|June 14, 2024
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastomaAndrew E Sloan, Kathryn Winter, Mark R Gilbert, et al.
Neuro-Oncology|December 25, 2012
Comparing routes of delivery for nanoliposomal irinotecan shows superior anti-tumor activity of local administration in treating intracranial glioblastoma xenograftsPin-Yuan Chen, Tomoko Ozawa, Daryl C Drummond, et al.
Journal of Neuro-Oncology|October 14, 2008
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasNicholas Butowski, Kathleen R Lamborn, Bee L Lee, et al.
Pageof 10